Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lois Almadrones

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Journal of Oncology Nursing|June 19, 2007
Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancerLois Almadrones
Oncology Nursing Forum|March 11, 2005
Chemotherapy-induced peripheral neuropathyTerri Armstrong, Lois Almadrones, Mark R Gilbert
Oncology Nursing Forum|May 18, 2004
Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group studyLois Almadrones, Debroah B McGuire, Janet Ruth Walczak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology GroupDavid H Moore, James Donnelly, William P McGuire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Journal of Oncology Nursing|June 19, 2007
Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancerLois Almadrones
Oncology Nursing Forum|March 11, 2005
Chemotherapy-induced peripheral neuropathyTerri Armstrong, Lois Almadrones, Mark R Gilbert
Oncology Nursing Forum|May 18, 2004
Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group studyLois Almadrones, Debroah B McGuire, Janet Ruth Walczak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology GroupDavid H Moore, James Donnelly, William P McGuire, et al.
Pageof 1